Sei Investments CO Clovis Oncology, Inc. Transaction History

Sei Investments CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$12.81 - $25.67 $75,245 - $150,785	-5,874 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$17.66 - $30.28 $23,205 - $39,787	-1,314 Reduced 18.28%	5,874 $144,000
Q4 2018 Feb 13, 2019	BUY	$11.63 - $32.67 $83,375 - $234,211	7,169 Added 37731.58%	7,188 $128,000
Q3 2018 Nov 08, 2018	SELL	$29.37 - $49.48 $34,245 - $57,693	-1,166 Reduced 98.4%	19 $0
Q2 2018 Aug 03, 2018	SELL	$42.06 - $62.4 $102,710 - $152,380	-2,442 Reduced 67.33%	1,185 $54,000
Q1 2018 May 11, 2018	SELL	$50.12 - $67.72 $338,410 - $457,245	-6,752 Reduced 65.05%	3,627 $192,000
Q4 2017 Feb 08, 2018	SELL	$57.69 - $84.58 $77,823 - $114,098	-1,349 Reduced 11.5%	10,379 $706,000
Q3 2017 Nov 06, 2017	BUY	$67.17 - $84.81 $787,769 - $994,651	11,728	11,728 $966,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

Stay updated on Sei Investments CO with notifications on news.